Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

ovarian transitional cell carcinoma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

ovarian transitional cell carcinoma

MONDO:0006343

Also known as:malignant ovarian transitional cell neoplasmovarian transitional cell cancerovary transitional cell carcinoma

Find Clinical TrialsTrials

Overview

A carcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that resemble malignant urothelial cells. There is no morphologic evidence of a benign or borderline Brenner tumor component present.

Clinical Trials9 registered

Diagnosis

Biomarker and diagnostic research for ovarian transitional cell carcinoma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

9 clinical trials registered. Interventions under study include procedural interventions, drug therapy, other interventions, and biologic therapy. Pipeline includes 4 PHASE3, 3 PHASE2, 2 PHASE1. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT04739800](https://clinicaltrials.gov/study/NCT04739800)

Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 11:28 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 9 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Laboratory research	99	79%
Research summaries	17	14%
New treatment approaches	5	4%
Testing and diagnosis research	2	2%
Patient case studies	1	1%
Clinical study results	1	1%

ovarian transitional cell carcinoma

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications